A simplified acute kidney injury predictor following transcatheter aortic valve implantation: the ACEF score

Abstract

This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives 4.0 International License (CC BY-NC-ND 4.0), allowing third parties to download articles and share them with others, provided the original work is properly cited, not changed in any way, distributed under the same license, and used for noncommercial purposes only.

Acute Kidney Injury Following Transcatheter Aortic Valve Implantation: Association with Contrast Media Dosage and Contrast Media Based Risk Predication Models

“…In several previous studies there was no significant difference in the volume of CM delivered during TAVI, between AKI+ patients and AKI− patients, nor between CM dose and post-procedural AKI [ 2 , 4 , 5 , 8 , 16 ]. Conversely, other studies described higher dosages of CM in AKI+ patients compared to AKI, and an association between the volume of CM delivered during TAVI and the subsequent development of AKI [ 6 , 9 , 10 , 25 , 26 ].…”

“…While in some studies LVEF was dis-concordantly associated with post-TAVI AKI, in other publications it was not [6,7,10,23,25,26]. Even decreasing baseline eGFR and chronic kidney dysfunction have an uncertain magnitude of effects on post-TAVI AKI [3,[6][7][8]10,[25][26][27]. The relationship between CM volume and TAVI-related AKI is also controversial.…”

“…For instance, while some studies demonstrated a relationship between increasing age and AKI development following TAVI, other studies did not [3,6,7,10,25]. While in some studies LVEF was dis-concordantly associated with post-TAVI AKI, in other publications it was not [6,7,10,23,25,26]. Even decreasing baseline eGFR and chronic kidney dysfunction have an uncertain magnitude of effects on post-TAVI AKI [3,[6][7][8]10,[25][26][27].…”

“…For instance, Zivcovic et al introduced an AKI risk calculator that was meant to be utilized prior to TAVI and therefore did not include a CM component [ 27 ]. As in this study, several previous studies tested the effectiveness of CM-based, non-TAVI dedicated risk models in predicting AKI following TAVI [ 6 , 15 , 16 , 24 , 26 , 50 ]. In our study, none of the CM-based risk models we tested independently predicted post-TAVI AKI.…”

Clinical Data, Chest Radiograph and Electrocardiography in the Screening for Left Ventricular Hypertrophy: The CAR2E2 Score

“…There is increasing interest in the use of markers and risk scores as well as in testing their clinical applicability in cardiovascular medicine [25][26][27][28][29][30][31][32][33]. Several factors have been found to be associated with LVH assessed by different modalities [7,16].…”